July 24, 2017 / 11:51 AM / 2 years ago

BRIEF-Concert Pharmaceuticals terminates Hart-Scott-Rodino act waiting period for CTP-656 asset purchase agreement

July 24 (Reuters) - Concert Pharmaceuticals Inc

* Concert Pharmaceuticals announces termination of the Hart-Scott-Rodino act waiting period for CTP-656 asset purchase agreement with Vertex

* Expiration of Hart-Scott-Rodino act waiting period represents final regulatory closing condition required to complete asset purchase

* Termination for pending sale of CTP-656 and other assets related to treatment of cystic fibrosis by Concert to Vertex Pharmaceuticals Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below